Thrombosis and infection: A case of transient anti-cardiolipin antibody associated with pylephlebitis

American Journal of the Medical Sciences

Volumn 325, Issue 6, 2003, Pages 365-368

  Liappis, Angelike P ^a   Roberts, Afsoon D ^a   Schwartz, Arnold M ^a   Simon, Gary L ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anti cardiolipin antibody; Bacteremia; Bacteroides; Mesenteric vein; Pylephlebitis; Thrombosis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CARDIOLIPIN ANTIBODY; ENZYME; HEPARIN LYASE;

ADULT; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTEROIDES; CASE REPORT; DISEASE ASSOCIATION; HUMAN; MALE; PATHOGENESIS; PHLEBITIS; THROMBOGENESIS; THROMBOSIS;

EID: 0037841295     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200306000-00008     Document Type: Article

References (14)

1. Plemmons RM, Dooley DP, Longfield RN. Septic thrombophlebitis of the portal vein (pylephlebitis): diagnosis and management in the modern era. Clin Infect Dis 1995;21:1114-20.
2. Bick RL, Baker WF. Anticardiolpin antibodies and thrombosis. Hematol Oncol Clin North Am 1992;6:1287-97.
3. Perangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 1994;3:247-51.
4. McNally T, Purdy G, Mackie IJ, et al. The use of an anti-β2-glycoprotein assay for discrimination between anticardiolipin antibodies associated with infection and increased risk of thrombosis. Br J Haematol 1995;91:471-3.
5. Sammaritano LR, Gharavi AE. Antiphospholipid antibody syndrome. Clin Lab Med 1992;12:41-59.
6. Azzundin EG and Lockshin MD. Antiphospholipid antibody tests In: Rose NR, Hamilton RG, Detrick B, editors. Manual of clinical laboratory immunology, 6th ed. Washington DC: ASM Press; 2002. p. 973-80.
7. Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002;126:1424-9.
8. Ameriso SF, Wong VL, Quismorio FP, et al. Immunohematologic characteristics of infection-associated cerebral infarction. Stroke 1991;22:1004-9.
9. Macko RF, Ameriso SF, Gruber A, et al. Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke 1996;27:2005-11.
10. Baril N, Wren S, Radin R, et al. The role of anticoagulation in pylephlebitis. Am J Surg 1996;172:449-52.
11. Lee HJ, Park JW, Chang JC. Mesenteric and portal venous obstruction associated with the primary anti-phospholipid antibody syndrome. J Gasteroenterol Hepatol 1997;12:822-6.
12. Bjornson HS, Hill EO. Bacteroidaceae in thromboembolic disease: effects of cell wall components on blood coagulation in vivo and in vitro. Infect Immunol 1979;8:911-8.
13. Hofstad T. Virulence factors in anaerobic bacteria. Eur J Clin Microbiol Infect Dis 1992;11:1044-8.
14. Bjornson HS. Activation of Hageman factor by lipopolysaccharides of Bacteroides fragilis, Bacteroides vulgatus and Fusobacterium mortiferum. Rev Infect Dis 1984;6 Suppl 1:S30-3.